Drug treatment in schizophrenia.
D002090:Butyrophenones / Q000627:therapeutic use; D002746:Chlorpromazine / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D006801:Humans; D010640:Phenothiazines / Q000627:therapeutic use*; D010649:Phenylalanine / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism; D013888:Thiothixene / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014364:Tryptophan / Q000378:metabolism; D014966:Xanthenes / Q000627:therapeutic use*
D002090:Butyrophenones; D010640:Phenothiazines; D014149:Tranquilizing Agents; D014966:Xanthenes; D010649:Phenylalanine; D013888:Thiothixene; D012110:Reserpine; D014364:Tryptophan; D002746:Chlorpromazine